|
|
Volumn 7, Issue 4, 2006, Pages 225-227
|
|
Editorial: Are peptides the future?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADALIMUMAB;
AMINO ACID;
ANTIMICROBIAL CATIONIC PEPTIDE;
APOLIPOPROTEIN A1;
BEVACIZUMAB;
CHOLESTEROL;
ENFUVIRTIDE;
ERYTHROPOIETIN;
ETANERCEPT;
EXENDIN 4;
GRANULOCYTE COLONY STIMULATING FACTOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INFLIXIMAB;
INSULIN;
MATRIX METALLOPROTEINASE;
METHOTREXATE;
OLIGONUCLEOTIDE;
PEPTIDE DERIVATIVE;
PHOSPHOTRANSFERASE;
PROTEIN DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
BIOLOGICAL PRODUCT;
PEPTIDE;
ANTIINFLAMMATORY ACTIVITY;
CANCER;
DIABETES MELLITUS;
DISEASE MODEL;
DRUG DESIGN;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG SPECIFICITY;
DRUG STABILITY;
DRUG SYNTHESIS;
DRUG TARGETING;
EDITORIAL;
ENZYME INHIBITION;
HUMAN;
INFLAMMATION;
NONHUMAN;
PHAGE DISPLAY;
PROTEIN FUNCTION;
RHEUMATOID ARTHRITIS;
UNSPECIFIED SIDE EFFECT;
CHEMISTRY;
ECONOMICS;
GENETICS;
MOLECULAR MIMICRY;
BIOLOGICAL PRODUCTS;
DRUG INDUSTRY;
MOLECULAR MIMICRY;
PEPTIDES;
|
|
EID: 33746862963
PISSN: 13892010
EISSN: None
Source Type: Journal
DOI: 10.2174/138920106777950799 Document Type: Editorial |
|
Times cited : (4)
|
|
References (9)
|
